Viatris (VTRS) Tax Rate Growth (3y) (2022 - 2026)
Viatris (VTRS) Tax Rate Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,096.00 |
| Dec 31, 2025 | -3,031.00 |
| Sep 30, 2025 | -153,991.00 |
| Jun 30, 2025 | 7,851.00 |
| Mar 31, 2025 | -2,255.00 |
| Dec 31, 2024 | 3,128.00 |
| Sep 30, 2024 | 5,108.00 |
| Jun 30, 2024 | 4,412.00 |
| Mar 31, 2024 | 17,945.00 |
| Dec 31, 2023 | 82.00 |
| Sep 30, 2023 | -598.00 |
| Jun 30, 2023 | -428.00 |
| Mar 31, 2023 | -188.00 |
| Dec 31, 2022 | -5,796.00 |